Welcome to our dedicated page for HANOVER INSURANCE GROUP SEC filings (Ticker: THG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HANOVER INSURANCE GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HANOVER INSURANCE GROUP's regulatory disclosures and financial reporting.
Ward Elizabeth A reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP director Elizabeth A. Ward received an equity grant of 843 shares of common stock in the form of restricted stock units at no cost. Following this grant, she directly owns 5,879 shares. The units were granted under the 2022 Long-Term Incentive Plan and vest on the earlier of one year from grant or the next annual meeting.
LANE KATHY S reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Kathy S. Lane received an equity grant tied to company performance and retention. She was awarded 843 restricted stock units of common stock under the company’s 2022 Long-Term Incentive Plan at no cash cost. These units vest on the earlier of one year from the grant date or the next annual meeting, and she has elected to defer the shares upon vesting under a deferral agreement. After this award, she directly holds 2,769 common shares, and a footnote states that this does not include 4,829 additional shares held indirectly in a Rabbi Trust under separate deferral arrangements.
RAMRATH JOSEPH R reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Joseph R. Ramrath received a grant of 843 shares of Common Stock in the form of restricted stock units under the company’s 2022 Long-Term Incentive Plan. These units vest on the earlier of one year from grant or the next annual meeting. Following this award, he directly holds 33,830 shares.
Condrin J Paul reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director J Paul Condrin reported an equity award rather than a market trade. On 2026-05-12, he received 843 shares of common stock in the form of restricted stock units granted at no cash cost to him.
The award was made under the company’s 2022 Long-Term Incentive Plan and will vest on the earlier of the one-year anniversary of the grant date or the next annual meeting. Following this grant, Condrin directly holds 6,352 shares of Hanover common stock.
Bunting Theodore H JR reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Theodore H. Bunting Jr. received an award of 843 shares of common stock on May 12, 2026, recorded at no cash price per share. These are restricted stock units granted under the company’s 2022 Long-Term Incentive Plan and will vest on the earlier of one year from the grant date or the next annual meeting. Following this grant, Bunting directly owns 7,031 shares of common stock.
Bradicich Kevin reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP director Kevin Bradicich received an equity award. He was granted 843 shares of common stock in the form of restricted stock units at a stated price of $0.00 per share under the company’s 2022 Long-Term Incentive Plan.
The units vest on the earlier of one year from the grant date or the next annual meeting. Following this grant, Bradicich holds 10,092 common shares directly, making this a relatively small, routine compensation-related award rather than a market purchase or sale.
Aristeguieta Francisco reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP director Francisco Aristeguieta received a grant of 843 shares of Common Stock as a compensation award. The grant is in the form of restricted stock units under the 2022 Long-Term Incentive Plan and will vest on the earlier of one year from grant or the next annual meeting, bringing his direct holdings to 5,053 shares.
The Hanover Insurance Group reported several governance and capital actions. The board appointed Patricia A. Norton-Gatto, Senior Vice President and Corporate Controller, as Principal Accounting Officer, replacing CFO Jeffrey M. Farber in that role. Shareholders re-elected eight directors, approved the advisory vote on executive compensation, and ratified PricewaterhouseCoopers LLP as independent auditor for 2026, each with strong support.
The board also terminated the prior share repurchase program and authorized a new $700 million share repurchase program with no time limit, replacing a program that had about $63 million remaining. Repurchases may occur in the open market, through privately negotiated or accelerated transactions, or other methods, at the company’s discretion.
Carlin Jane D reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Jane D. Carlin reported an equity grant in the form of 843 shares of common stock on May 12, 2026. The award was granted at no cash cost to her and is described as restricted stock units under the company’s 2022 Long-Term Incentive Plan.
These units vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting. After this grant, Carlin directly holds 3,266 common shares. A footnote also notes an additional 2,306 shares held indirectly in a Rabbi Trust pursuant to deferral agreements, separate from the reported direct holdings.
HANOVER INSURANCE GROUP, INC. director Cynthia Egan reported receiving an equity award in the form of 843 shares of common stock at $0.00 per share, classified as a grant or award acquisition. This grant was issued as restricted stock units under the company’s 2022 Long-Term Incentive Plan.
The units vest on the earlier of the one-year anniversary of the grant date or the next annual meeting, and Egan has elected to defer the grant upon vesting under a deferral agreement. After this award, she directly owns 10,202 shares of common stock, and a footnote states this does not include 977 shares held indirectly in a Rabbi Trust under deferral agreements.